http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0440483-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_700ff9a01db2075489cb7ed87392dc28
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-065
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-06
filingDate 1991-01-31^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4eb6ec442437af709008464a5696de6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5472872cd6bff9530f86a256af1617c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e0082aba78ec6380598499c74ff5912
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e74623667fb4c664ebff3dd4c7b05039
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dcfa5151047260c7a45080612dd832b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b03017c0e33d65b8a2fcf21785d9e89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77eb9688d009da9d787f7c27b83a2dbb
publicationDate 1991-08-07^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0440483-A2
titleOfInvention Process for purifying immune serum globulins
abstract A multi-step process for purifying an immune serum globulin fraction from a crude plasma protein fraction involves precipitating non-serum globulin proteins from an aqueous suspension of the crude plasma protein fraction using a protein precipitant, adding a virus-inactivating agent to the clarified immune serum globulin-containing liquid, absorbing the immune serum globulins onto a cation exchange resin and washing non-serum globulin contaminants from the resin, subjecting the eluate to ultrafiltration to concentrate the immune serum globulins and separate them from low molecular weight species, contacting the concentrate with an anion exchange resin to absorb non-serum globulin contaminants, passing the immune-serum globulins through the anion exchange resin under conditions that leave non-serum globulin contaminants bound to the resin, and subjecting the filtrate to a molecular washing step to produce a purified immune serum globulin fraction. This process results in products substantially free of active viruses and contaminating lipids, activated complements and low molecular weight peptides. In addition, the process is advantageous in terms of efficiency and adaptability to large-scale production.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1044696-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1561756-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20140062088-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1928915-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10301376-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11760778-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9918130-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5593675-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-030251-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8933204-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1928915-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9518155-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2010337871-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11034754-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011034604-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011080698-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10654888-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE44558-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10815270-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6069236-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013033042-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9403899-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9429334-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0659767-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11028125-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0893450-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2012300220-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2012300220-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE43655-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8293242-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2706466-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-FI20090273-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9631007-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1044696-A2
priorityDate 1990-02-01^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3869436-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0268973-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408552
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373926
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31357
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395791
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81070
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22775

Showing number of triples: 1 to 72 of 72.